Muegge, B.D
The Medicare GLP-1 Bridge will be available nationwide across all states and territories, providing eligible patients access to all doses and formulations of Wegovy injection and Wegovy pill, and will run through the end of 2027
AF risk escalates in parallel with increased BMI, thus obesity, a public health issue as well as the most common metabolic disorder in human, is regarded as the second biggest attributable risk factor for AF (Wong et al., 2015)
doi: 10.7326/0003-4819-152-9-201005040-00007
Nausea, vomiting, constipation, and appetite suppression occur across the class, though timing and severity vary between people
Institutional Review Board Statement The CHHRS and the present study were conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Anhui Medical University (protocol code: CH1049, June 2018)